Neoadjuvant durvalumab plus chemotherapy in resectable or borderline resectable non-small-cell lung cancer: the phase 2 MDT-BRIDGE trial. (nature.com)

Authors: Reck M … Spicer J Journal: Nature Medicine Published: 2026-10-26 DOI: https://doi.org/10.1038/s41591-026-04742-7